04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
Although semaglutide had limited effects on hyperglycemia and weight loss, it improved lipid profiles and reduced oxidative stress [86]
Support your GLP1 journey from start to finish with our allinone GLP1 Support Kit
This cutting-edge technology strengthens our Neuroscience Center of Excellence and Wellstar Georgia Cancer Center, but most importantly, it ensures that patients from across the region have access to world-class, non-invasive treatment options close to home. The addition of the Gamma Knife Esprit further reinforces Wellstar MCG Healths position as a leader in advanced neurological and cancer care
Early clinical data suggests GI side effects are common but manageable